Form 4 for ELAN Elanco Animal Health Inc
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001415889-24-006648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +187.2K | 1.42M | +15% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | F - Tax | $16.03 | -48.4K | 1.37M | -3% | -$776.3K |
| D | 2024-03-05 | 2024-03-01 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +408.2K | 408.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 187,150 | $0.00 | 1,415,892 | D | — | — | (F1) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. |
| 2 | Common | Common Stock | 2024-03-01 | F | D | 48,425 | $16.03 | 1,367,467 | D | — | — | (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. |
| 3 | Derivative | Employee Stock Option(right to buy) | 2024-03-01 | A | A | 408,164 | $0.00 | 408,164 | D | $16.03 · — to 2034-03-01 | 408,164 Common Stock | (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. |